Davis R M Inc Bristol Myers Squibb CO Transaction History

Davis R M Inc

$5.09 Billion
Q3 2024

A detailed history of Davis R M Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Davis R M Inc holds 6,895 shares of BMY stock, worth $401,495. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,895

Previous 9,369 26.41%

Holding current value

$401,495

Previous $389,000 8.48%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $98,118 - $128,029	-2,474 Reduced 26.41%	6,895 $356,000
Q2 2024 Aug 09, 2024	BUY	$40.25 - $52.99 $9,056 - $11,922	225 Added 2.46%	9,369 $389,000
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $6,957 - $7,888	-145 Reduced 1.56%	9,144 $495,000
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $59,291 - $70,750	-1,223 Reduced 11.63%	9,289 $476,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $79,367 - $88,744	-1,371 Reduced 11.54%	10,512 $610,000
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $82,122 - $91,183	1,289 Added 12.17%	11,883 $760,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $4,271 - $4,844	65 Added 0.62%	10,594 $734,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $40,403 - $47,843	590 Added 5.94%	10,529 $758,000
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $13 - $7,684	100 Added 1.02%	9,939 $707,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $69,569 - $76,620	958 Added 10.79%	9,839 $758,000
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $39,224 - $47,033	638 Added 7.74%	8,881 $649,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $53 - $62	-1 Reduced 0.01%	8,243 $514,000
Q3 2021 Nov 08, 2021	SELL	$59.17 - $69.31 $16,685 - $19,545	-282 Reduced 3.31%	8,244 $488,000
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $36,217 - $39,440	585 Added 7.37%	8,526 $570,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $111,855 - $125,804	-1,885 Reduced 19.18%	7,941 $501,000
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $20,439 - $23,162	354 Added 3.74%	9,826 $610,000
Q3 2020 Dec 01, 2020	SELL	$57.43 - $63.64 $82,010 - $90,877	-1,428 Reduced 13.1%	9,472 $571,000
Q2 2020 Jul 20, 2020	SELL	$54.82 - $64.09 $63,700 - $74,472	-1,162 Reduced 9.63%	10,900 $641,000
Q1 2020 Apr 24, 2020	BUY	$46.4 - $67.43 $12,342 - $17,936	266 Added 2.26%	12,062 $672,000
Q4 2019 Jan 23, 2020	SELL	$49.21 - $64.19 $29,427 - $38,385	-598 Reduced 4.82%	11,796 $757,000
Q3 2019 Oct 24, 2019	SELL	$42.77 - $50.71 $23,437 - $27,789	-548 Reduced 4.23%	12,394 $628,000
Q2 2019 Jul 31, 2019	SELL	$44.62 - $49.34 $51,357 - $56,790	-1,151 Reduced 8.17%	12,942 $587,000
Q1 2019 Apr 29, 2019	SELL	$45.12 - $53.8 $12,408 - $14,795	-275 Reduced 1.91%	14,093 $672,000
Q4 2018 Jan 18, 2019	SELL	$48.76 - $63.23 $132,627 - $171,985	-2,720 Reduced 15.92%	14,368 $747,000
Q3 2018 Oct 17, 2018	SELL	$55.19 - $62.25 $12,638 - $14,255	-229 Reduced 1.32%	17,088 $1.06 Million
Q2 2018 Jul 19, 2018	SELL	$50.53 - $62.98 $132,287 - $164,881	-2,618 Reduced 13.13%	17,317 $958,000
Q1 2018 Apr 19, 2018	SELL	$59.92 - $68.98 $74,420 - $85,673	-1,242 Reduced 5.86%	19,935 $1.26 Million
Q4 2017 Jan 16, 2018	SELL	$59.94 - $65.35 $47,952 - $52,279	-800 Reduced 3.64%	21,177 $1.3 Million
Q3 2017 Oct 24, 2017	BUY	$55.23 - $63.74 $1.21 Million - $1.4 Million	21,977	21,977 $1.4 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

News

Stay updated on Davis R M Inc with notifications on news.

Account